Start Submission Become a Reviewer

Reading: Glucose Management, Heart Failure and Transplantation

Download

A- A+
Alt. Display

Review Articles

Glucose Management, Heart Failure and Transplantation

Authors:

Dale J. Hamilton ,

Methodist Diabetes Heart Program and Methodist DeBakey Heart & Vascular Center, Houston, Texas, US
About Dale J.
M.D.
X close

Saundra J. Hendricks,

Methodist Diabetes Heart Program and Methodist DeBakey Heart & Vascular Center, Houston, Texas, US
About Saundra J.
M.S.
X close

Eunice lhaza,

Methodist Diabetes Heart Program and Methodist DeBakey Heart & Vascular Center, Houston, Texas, US
About Eunice
M.S.
X close

Johnny L. Rollins

Methodist Diabetes Heart Program and Methodist DeBakey Heart & Vascular Center, Houston, Texas, US
About Johnny L.
M.S.N.
X close

Abstract

Glucose control before, during, and after orthotropic heart transplantation presents unique challenges. The presence of advanced heart failure contradicts the use of oral metformin and thiozolidinediones (TZDs). The benefit of insulin has been questioned, and recent investigations question the degree of glycemic control in the ICU.1 Scant published data report on the efficacy of oral hypoglycemics on graft function and survival. The purpose of this summary is to present our approach to patients either listed for or undergoing heart transplantation at The Methodist Hospital.

How to Cite: 1. Hamilton DJ, Hendricks SJ, lhaza E, Rollins JL. Glucose Management, Heart Failure and Transplantation. Methodist DeBakey Cardiovascular Journal. 2009;5(3):12-15. DOI: http://doi.org/10.14797/mdcvj.166
Published on 01 Jan 2009.
Peer Reviewed

Downloads

  • PDF (EN)